F042-0629 Screening compound: 2-(2-{[(3-chlorophenyl)carbamoyl]amino}-1,3-thiazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide

F042-0629 Screening compound: 2-(2-{[(3-chlorophenyl)carbamoyl]amino}-1,3-thiazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide
F042-0629 Screening compound: 2-(2-{[(3-chlorophenyl)carbamoyl]amino}-1,3-thiazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F042-0629
2-(2-{[(3-chlorophenyl)carbamoyl]amino}-1,3-thiazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F042-0629

Molecular Formula

C19H14ClF3N4O3S (C19 H14 ClF3 N4 O3 S)

Compound Name

2-(2-{[(3-chlorophenyl)carbamoyl]amino}-1,3-thiazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide

IUPAC name

2-(2-{[(3-chlorophenyl)carbamoyl]amino}-13-thiazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide

SMILES

O=C(Cc1csc(NC(Nc2cccc(Cl)c2)=O)n1)Nc(cc1)ccc1OC(F)(F)F

InChI

InChI=1S/C19H14ClF3N4O3S/c20-11-2-1-3-13(8-11)25-17(29)27-18-26-14(10-31-18)9-16(28)24-12-4-6-15(7-5-12)30-19(21,22)23/h1-8,10H,9H2,(H,24,28)(H2,25,26,27,29)

InChI Key

BJZVDTQQLPHVJJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09240438

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.86

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.172

Distribution Coefficient, logD

6.170

Water Solubility, LogSw

-6.33

Polar Surface Area

71.898

Acid Dissociation Constant (pKa)

9.65

Base Dissociation Constant (pKb)

1.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.50

F042-0629 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F042-0629 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F042-0629?
Check Price and Availability of F042-0629, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F042-0629 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F042-0629
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F042-0629
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F042-0629 available by request